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| INTRODUCTION

Subcutaneous implantable cardioverter defibrillators (S-ICD)
have become a reasonable alternative to single-chamber transvenous ICD systems for patients who pass the screening protocol. 1, 2 There is limited experience however in managing patients who require a sternotomy who have previously had a S-ICD placed. Concerns over lead damage, lead positioning poststernotomy, and possible contact between the lead and the sternotomy wires are the main concerns that may result in device malfunction.
| CASE REPORT
A 63-year-old African American diabetic women with known severe ischemic cardiomyopathy (EF 25%) with multiple prior revascularizations with drug-eluting stents, NYHA class II symptoms without angina who was on maximally tolerated goaldirected medical therapy for greater than 90 days after her last revascularization underwent S-ICD placement in June 2016 ( Figure  1A+B ). In 2018, the patient presented with unstable angina underwent cardiac catheterization and found to have progressive severe triple-vessel disease. She was subsequently evaluated for coronary artery bypass grafting (CABG) and deemed to be an appropriate candidate. A decision to attempt to perform CABG with caution to avoid damage to the S-ICD lead was made. A PEAK PlasmaBlade was used to dissect and isolate the S-ICD away from sternotomy to minimize risk of damage to lead (Figure 2 ). Primary median sternotomy and CABG were then performed in standard fashion. Following sternal closure with stainless steel wires, a soft tissue tunneller was used to relocate the S-ICD approximately 2 cm lateral to primary dissection plane in the subcutaneous fat. This ensured no interaction with the stainless steel wires ( Figure 1C ,D). The lead was secured superiorly and inferiorly with sutures, and wound was closed in multiple layers using absorbable suture. Repeat S-ICD testing postprocedure was not performed. The patient was discharged subsequently without any complications. Follow-up indicates the patient has no recurrent angina. Subsequent ICD interrogations have revealed no evidence of device malfunction and no evidence of ICD discharges.
| DISCUSSION
This is the second case report that highlights the possibility of safely doing a sternotomy in a patient with S-ICD and how to re-position the lead once done to avoid unwanted complications. The first case reported was in a patient who required sternotomy for LVAD placement and described a technique similar to that performed by us: specifically, visualization of the S-ICD lead and blunt dissection to avoid procedural trauma, isolation of the S-ICD lead for the remaining duration of the procedure, and subsequently re-implanting the S-ICD lead on the left parasternal region in a plane separate from the sternal wires. 3 The use of an electrocautery tool such as the PlasmaBlade cautery pen that does not cause thermal injury to the insulation of the lead should be considered highly preferable in cases where preservation of the S-ICD lead is planned. The positioning of the S-ICD lead in a plane separate from the sternal wires as well as far enough from the wires is to avoid electric interference and inappropriate shocks as previously reported by Winter et al 4 Although repeat defibrillation testing would have been reasonable in this case, defibrillation testing was not performed in the operating room or postoperatively due to the fact that the patient had just undergone a sternotomy. Furthermore, the best predictor of low energy requirements for the subcutaneous defibrillator is a posterior location of the generator, which was not moved in this case. Device-based sensing using the optimal vector was effectively unchanged postoperatively.
| CONCLUSION
This case report further highlights the feasibility and safety of performing sternotomy in patients post-S-ICD placement and how to ideally position the S-ICD lead during re-implant to avoid unwanted complications of lead malfunction and inappropriate shocks. It remains to be seen if repeat DFT testing is indicated in patients poststernotomy.
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